Professional and Reliable IHC Raw Antibody Solutions for Breast Pathology
Breast tissue presents unique challenges due to its structural heterogeneity and variable marker expression. AREX provides high-quality IHC raw antibodies optimized for this complexity, supporting detection of hormone receptors, growth factor receptors, proliferation markers, and other relevant targets to aid in breast cancer diagnosis, classification, and prognostic assessment.
Core Advantages:
High specificity and low background for precise staining in breast tissue
Good sensitivity delivering clear signals even in heterogeneous samples
Excellent batch-to-batch consistency suitable for R&D to large-scale OEM supply
AREX breast pathology raw antibodies integrate seamlessly with our
ARExVisual® micropolymer detection system and
Ancillaries supporting reagents to deliver a complete IHC solution.
Contact us to request catalogs, sample testing, or technical consultation.